{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T14:26:00Z","timestamp":1770560760679,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ad.2011.01.015","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T00:58:55Z","timestamp":1311901135000},"page":"827-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alopecia areata y terapias biol\u00f3gicas. Presentaci\u00f3n de un caso asociado a adalimumab"],"prefix":"10.1016","volume":"102","author":[{"given":"J.","family":"Neila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carrizosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2011.01.015_bib0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","volume":"216","author":"Pelivani","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2011.01.015_bib0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-2133.1996.d01-1099.x","article-title":"Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor- alpha in alopecia areata","volume":"135","author":"Philpott","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2011.01.015_bib0015","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: an open label study","volume":"52","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.01.015_bib0020","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archdermatol.2009.264","article-title":"Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study","volume":"145","author":"Strober","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2011.01.015_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2007.10.645","article-title":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","volume":"58","author":"Price","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2011.01.015_bib0030","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/archderm.142.12.1654","article-title":"Development of alopecia areata universalis in a patient receiving adalimumab","volume":"142","author":"Garc\u00eda Bartels","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2011.01.015_bib0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000174826","article-title":"Biologic agents and alopecia areata","volume":"218","author":"Katoulis","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2011.01.015_bib0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000162180","article-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab)","volume":"217","author":"Chaves","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2011.01.015_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2310\/7750.2008.07095","article-title":"Alopecia areata following adalimumab","volume":"13","author":"Kirshen","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ad.2011.01.015_bib0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1468-3083.2010.03770.x","article-title":"Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-alpha blocker agents","volume":"25","author":"Ferran","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2011.01.015_bib0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/ar1715","article-title":"Sistemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey","volume":"7","author":"De Bandt","year":"2005","journal-title":"Arthritis Res Ther"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731011002250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731011002250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:57:11Z","timestamp":1757552231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731011002250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0001731011002250"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2011.01.015","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia areata y terapias biol\u00f3gicas. Presentaci\u00f3n de un caso asociado a adalimumab","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2011.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Espa\u00f1a, S.L. y AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}